An Indian parliamentary committee wants generics fully protected from future US tariff hikes under a bilateral trade deal, while also urging faster mutual recognition agreements, pre-clearance mechanisms and policy support for exposed exporters.
An Indian parliamentary committee wants generics fully protected from future US tariff hikes under a bilateral trade deal, while also urging faster mutual recognition agreements, pre-clearance mechanisms and policy support for exposed exporters.